Insert treats first patient with nano-engineered cancer compound
IT-101 is a combination of Insert’s patented polymer technology, Cyclosert, and the anticancer compound camptothecin. According to the company, Cyclosert is the first nanoparticulate drug delivery platform to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.